Cargando…
Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study
This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042191/ https://www.ncbi.nlm.nih.gov/pubmed/27729787 http://dx.doi.org/10.2147/IJN.S115742 |
_version_ | 1782456563833765888 |
---|---|
author | Zheng, Sisi Luo, Li Bo, Ruonan Liu, Zhenguang Xing, Jie Niu, Yale Hu, Yuanliang Liu, Jiaguo Wang, Deyun |
author_facet | Zheng, Sisi Luo, Li Bo, Ruonan Liu, Zhenguang Xing, Jie Niu, Yale Hu, Yuanliang Liu, Jiaguo Wang, Deyun |
author_sort | Zheng, Sisi |
collection | PubMed |
description | This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize PHYP nanospheres, and the optimal preparation conditions were identified as a concentration of poloxamer 188 (F68) (w/v) of 0.33%, a concentration of PLA of 30 mg/mL, and a ratio of PLA to drug (w/w) of 10.25:1 required to reach the highest encapsulation efficiency, which was calculated to be 59.10%. PHYP had a spherical shape with a smooth surface and uniform size and an evident effect of sustained release and relative stability. Splenic lymphocytes are crucial and multifunctional cells in the immune system, and their immunological properties could be enhanced significantly by PHYP treatment. This study confirmed that PHY encapsulated in PLA nanospheres had comparatively steady properties and exerted obvious immune enhancement. |
format | Online Article Text |
id | pubmed-5042191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50421912016-10-11 Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study Zheng, Sisi Luo, Li Bo, Ruonan Liu, Zhenguang Xing, Jie Niu, Yale Hu, Yuanliang Liu, Jiaguo Wang, Deyun Int J Nanomedicine Original Research This study aimed to optimize the preparation conditions of pachyman (PHY)-loaded poly(d,l-lactic acid) (PLA) (PHYP) nanospheres by response surface methodology, explore their characteristics, and assess their effects on splenic lymphocytes. Double emulsion solvent evaporation was used to synthesize PHYP nanospheres, and the optimal preparation conditions were identified as a concentration of poloxamer 188 (F68) (w/v) of 0.33%, a concentration of PLA of 30 mg/mL, and a ratio of PLA to drug (w/w) of 10.25:1 required to reach the highest encapsulation efficiency, which was calculated to be 59.10%. PHYP had a spherical shape with a smooth surface and uniform size and an evident effect of sustained release and relative stability. Splenic lymphocytes are crucial and multifunctional cells in the immune system, and their immunological properties could be enhanced significantly by PHYP treatment. This study confirmed that PHY encapsulated in PLA nanospheres had comparatively steady properties and exerted obvious immune enhancement. Dove Medical Press 2016-09-23 /pmc/articles/PMC5042191/ /pubmed/27729787 http://dx.doi.org/10.2147/IJN.S115742 Text en © 2016 Zheng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Zheng, Sisi Luo, Li Bo, Ruonan Liu, Zhenguang Xing, Jie Niu, Yale Hu, Yuanliang Liu, Jiaguo Wang, Deyun Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title | Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title_full | Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title_fullStr | Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title_full_unstemmed | Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title_short | Evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
title_sort | evaluation of optimum conditions for pachyman encapsulated in poly(d,l-lactic acid) nanospheres by response surface methodology and results of a related in vitro study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042191/ https://www.ncbi.nlm.nih.gov/pubmed/27729787 http://dx.doi.org/10.2147/IJN.S115742 |
work_keys_str_mv | AT zhengsisi evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT luoli evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT boruonan evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT liuzhenguang evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT xingjie evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT niuyale evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT huyuanliang evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT liujiaguo evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy AT wangdeyun evaluationofoptimumconditionsforpachymanencapsulatedinpolydllacticacidnanospheresbyresponsesurfacemethodologyandresultsofarelatedinvitrostudy |